Virtual-reality self-hypnosis for HIV-related chronic pain
Official title: An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study
Run by Icahn School of Medicine at Mount Sinai · NCT06398847 · Data updated 2026-11-12
This trial will try a virtual-reality self-hypnosis program to see if it reduces chronic pain in adults living with HIV.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | March 26, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT06398847 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) living with HIV who have had chronic HIV-associated pain for at least 90 days, are on a stable antiretroviral regimen and stable pain management for ≥90 days, report average pain ≥3, speak English, and can access the internet are ideal candidates.
✕Probably not a fit
Patients with unstable medical or psychiatric conditions, those currently in other investigational pain protocols, or those unable to tolerate or use VR technology are less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project uses an off-the-shelf VR headset (OculusGo) paired with self-hypnosis software developed by the study team to test safety, usability, and preliminary pain relief. Work is organized in two phases: Phase A involves software development and internal testing by the team, and Phase B enrolls participants to use the VR intervention. This single-site study at the Icahn School of Medicine at Mount Sinai received an FDA non-significant risk exemption. Participants will be adults with documented HIV-associated chronic pain on stable antiretroviral and pain regimens and will report baseline pain intensity of at least 3 on the numeric rating scale.
Why it matters
Potential benefit: If successful, this could provide a non-drug, accessible tool to lessen HIV-associated chronic pain symptoms.
How similar studies have gone: Prior work shows VR and self-hypnosis can reduce pain in other chronic pain groups, but combining VR-delivered self-hypnosis specifically for HIV-related pain is relatively novel and has only preliminary data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Eligibility Inclusion Criteria: * Adults age ≥18 * Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days. * Documentation of chronic pain associated with HIV for≥90 days * Stable pain management regimen ≥90 days, or no pain treatments ≥90 days * Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2 * Access to the internet via smartphone, computer, or tablet 7. Fluent in English * Capable of giving informed consent and willingness to comply with study procedures. Exclusion Criteria: * A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention. * Concurrent participation in another investigational protocol for pain treatment * A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures. * Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices. * A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment * Injury to eyes, face, or neck that impedes using the VR device * If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol. * Currently pregnant or planning to become pregnant during the study period
Where it's running
-
Icahn School of Medicine at Mount Sinai
New York, New York, United States Recruiting
Study contacts
- Study coordinator: Mary Catherine George, PhD
- Email: mary-catherine.george@mssm.edu
- Phone: 646-808-6231
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Relationship between high PainDETECT scores, pain location, and diagnosis in musculoskeletal care
See if PainDETECT questionnaire scores relate to pain locations and clinical diagnoses in adults with musculoskeletal pain who visit a sports medicine clinic.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Physical activity and musculoskeletal pain among lawyers
Agroup of lawyers will be categorized by how physically active they are to see if activity levels relate to how often and where they have musculoskeletal pain and how this connects to stress and job satisfaction.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.